Indo-MIM has grown into the world’s largest metal injection molding manufacturer by revenue, running 15 facilities across India, the US, the UK and Mexico, serving over 1,100 customers across automotive, defence, medical, consumer and aerospace sectors. They are filing a fresh issue of up to ~₹500 Cr, alongside an offer for sale of up to ₹3,311 Cr.
IPO Overview
Introduction
Indo-MIM Limited makes small, high-precision metal parts like triggers for firearms, housings for surgical staplers, or fuel system components for cars. They do so using a process called Metal Injection Molding (MIM), turning metal powder into finished parts at a very large scale that only a few competitors can match.
Indo-MIM holds a ~7% share of the global MIM market and are actually the largest makers of precision engineering components using MIM technology by revenue, and has led the industry for six straight years, according to a Frost & Sullivan report commissioned by the company.
It operates 15 manufacturing facilities across India, the United States, the United Kingdom and Mexico, and served more than 1,100 customers in FY26.
The Business Model
Indo-MIM operates in five product groups:
1. Automotive (fuel systems, powertrains, etc)
2. Defence (firearm components like triggers and sights)
3. Medical (surgical/orthopaedic parts)
4. Consumer (fashion, phone components)
5. Aerospace (housings, adaptors, brackets).
It manufactured over 9,000 distinct products in Fiscal 2026.
The manufacturing process runs in three core steps.
Compounding mixes metal powder with polymer binder into a consistent feedstock.
Injection molding shapes that feedstock into the rough part geometry using automated, closed-loop machines.
Debinding and sintering then remove the binder and fuse the metal particles under heat, producing the finished part.
Indo-MIM sells on a purchase order basis. It does not hold long-term supply contracts with fixed volumes. Revenue depends on repeat business rather than contractual commitments. In fact, repeat customers contributed ~92% of revenue in FY26.
The company runs 15 manufacturing facilities: six in India, six in the US, two in the UK, and one in Mexico.
This model lets it serve locally as well as globally, and the manufacturing process itself is broadly fungible across product categories.
Unit Economics
- Revenue per part manufactured rose from ₹115 in FY24 to ₹150 in FY26, a 30% increase, even as material cost per part climbed 74% over the same period.
- On a similar note, adjusted EBITDA per part improved from ₹30 to ₹38 across FY24-26.
- Total parts manufactured itself fell from 316 million in FY5 to 280 million in FY26.
Operating Metrics
- Revenue has been increasingly shifting outside of Indo-MIM’s core operations, with the sale of powder, tools, and other items making up 16% of all revenue from operations in FY26, up from just 3% in FY24.
- Revenue from outside India fell to 77% in FY26 from 88% in FY24 and 90% in FY25, due to two new large domestic customers in FY26 adding about ₹491 Cr in revenue.
- Indo-MIM relies on primary raw materials such as metal powders and polymers for a lot of their products. Costs for these materials as a percent of revenue has been rising from 16% in FY24 to now 21% in FY26.
The Financials
- Revenue from Operations climbed from ₹2,870 Cr to ₹4,193 Cr from FY24 to FY26, as two Indo-MIM got two new large domestic customers and revenue from sale of powder, tools, etc also grew.
- Finance Costs nearly doubled, from ₹87 Cr in FY24 to ₹167 Cr in FY26, a CAGR of ~39%. Yet, debt to equity fell from 0.53x in FY24 to 0.39x in FY26.
- Profit After Tax rose 88% in two years, from ₹284 Cr in FY24 to ₹534 Cr in FY26, but PAT Margins stalled in FY26, as rising Finance Costs ate into gains.
Indo-MIM’s Peers
Important Note: Jiangsu Gian is a China based peer, and its Financials are taken according to the Chinese financial year, which runs from Jan-Dec. Note that all data is taken from Indo-MIM’s RHP.
- Indo-MIM’s EBITDA margin of 26% is nearly 11% above Jiangsu Gian’s, despite both companies competing in the same MIM industry.
- Indo-MIM’s PAT Margin of 13% is also more than five times Jiangsu Gian’s 2%, on revenue about 3% higher than its peer’s.
- One important thing to note is also that this comparison rests on a single global peer, since the company states no listed Indian business is directly comparable.
Key Risks
- Customer concentration without contractual protection. Indo-MIM’s top 10 customers contributed 38% of FY26 revenue, and still, Indo-MIM has no long-term contracts with any of its customers. Orders are placed on a purchase order basis, and customers can shift to other suppliers without cause and without compensation.
- Export and tariff exposure. 77% of FY26 revenue came from outside India, mainly North America and Europe. Any increase in import duties on Indian automotive components is a risk to its business in a very large market.
Summary
Indo-MIM is one of the largest metal injection molding manufacturers in the world, and its financials stand on a base of expanding EBITDA margins, lower leverage, and diversification from its core businesses into sale of goods. However, investors appear to have limited domestic benchmarks to judge the company valuations.
